Financial Statements — MTEK
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 2.77 | 0.82 | 1.78 | 0.35 |
| Short-term Investments | -- | 3.02 | 5.08 | 11.04 |
| Accounts Receivable | 1.22 | 3.76 | 0.75 | 0.63 |
| Inventory | 2.74 | 1.88 | 1.39 | 0.53 |
| Total Current Assets | 6.99 | 9.67 | 9.65 | 13.13 |
| Property, Plant & Equipment | 0.36 | 0.45 | 0.33 | 0.08 |
| Total Non-current Assets | 1.00 | 1.21 | 1.08 | 0.96 |
| Total Assets | 7.99 | 10.88 | 10.74 | 14.10 |
| Short-term Debt | 2.00 | -- | -- | 0.41 |
| Total Current Liabilities | 3.79 | 2.71 | 1.80 | 1.11 |
| Long-term Debt | -- | -- | -- | 0.74 |
| Total Non-current Liabilities | 0.69 | 1.07 | 1.64 | 2.02 |
| Total Liabilities | 4.48 | 3.78 | 3.44 | 3.13 |
| Retained Earnings | (14.52) | (10.77) | (10.46) | (6.78) |
| Total Stockholder Equity | 3.51 | 7.10 | 7.30 | 10.97 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Total Revenue | 0.71 | 3.41 | 0.47 | 0.97 |
| Cost of Revenue | 0.71 | 1.48 | 0.64 | 0.65 |
| Gross Profit | 0.00 | 1.93 | (0.17) | 0.32 |
| Research & Development | 0.74 | 0.35 | 0.44 | 0.65 |
| Selling, General & Admin | 0.99 | 1.12 | 1.50 | 1.50 |
| Total Operating Expenses | 2.28 | 1.89 | 2.25 | 2.61 |
| Operating Income | (2.28) | 0.05 | (2.43) | (2.29) |
| Net Income | (2.39) | 0.13 | (2.26) | (2.27) |
| Basic EPS | (0.30) | 0.02 | (0.29) | (0.32) |
| Diluted EPS | (0.30) | 0.02 | (0.29) | (0.32) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (1.29) | (0.99) | (2.25) | (2.95) |
| Capital Expenditures | 0.01 | 0.17 | 0.07 | 0.06 |
| Free Cash Flow* | (1.30) | (1.16) | (2.32) | (3.01) |
| Investing Cash Flow | (0.01) | (0.05) | 3.93 | (11.09) |
| Financing Cash Flow | 1.78 | (0.19) | (0.12) | 14.37 |
* Derived from reported values
